Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
69,648
Sort by:
North America Healthcare CRM Market Forecast to 2030 - Regional Analysis - by Deployment Mode (Cloud Based and On-Premise), Product Type (Operational CRM, Analytical CRM, and Collaborative CRM), Application (Relationship Management, Case Management, Case Coordination, Community Outreach, and Others), and End User (Providers, Payers, and Others)
US$ 3,550.00
The North America healthcare CRM market was valued at US$ 2,469.03 million in 2022 and is expected to reach US$ 5,651.99 million by 2030; it is estimated to register a CAGR of 10.9% from 2022 to 2030....
May 2024
145 pages
North America Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment (Generic Drugs, Originators, Vaccines, and Others), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
US$ 3,550.00
The North America malaria treatment market was valued at US$ 62.97 million in 2022 and is expected to reach US$ 487.31 million by 2030; it is estimated to grow at a CAGR of 29.1% from 2022 to 2030. In...
May 2024
84 pages
South & Central America Healthcare CRM Market Forecast to 2030 - Regional Analysis - by Deployment Mode (Cloud Based and On-Premise), Product Type (Operational CRM, Analytical CRM, and Collaborative CRM), Application (Relationship Management, Case Management, Case Coordination, Community Outreach, and Others), and End User (Providers, Payers, and Others)
US$ 3,550.00
The South & Central America healthcare CRM market was valued at US$ 227.90 million in 2022 and is expected to reach US$ 474.97 million by 2030; it is estimated to register a CAGR of 9.6% from 2022 to...
May 2024
125 pages
South & Central America Malaria Treatment Market Forecast to 2030 - Regional Analysis - by Treatment (Generic Drugs, Originators, Vaccines, and Others), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
US$ 3,550.00
The South & Central America malaria treatment market was valued at US$ 59.68 million in 2022 and is expected to reach US$ 247.33 million by 2030; it is estimated to grow at a CAGR of 19.4% from 2022 t...
May 2024
75 pages
South & Central America Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), and End User (Biopharmaceutical Companies and Pharmaceutical Companies)
US$ 3,550.00
The South & Central America pharmaceutical contract sales organizations market is expected to grow from US$ 344.44 million in 2022 to US$ 621.93 million by 2030. It is estimated to grow at a CAGR of 7...
May 2024
73 pages
Drug Device Combination Products Market Size, Share & Trends Analysis Report By Product (Transdermal Patches, Infusion Pumps, Inhalers, Drug Eluting Stents), By Region, And Segment Forecasts, 2024 - 2030
US$ 5,950.00
The global drug device combination product market size is expected to reach USD 177.7 billion by 2024, according to a new ... the clinical urgency to incorporate alternatives based on targeted therapy, as in case of drug-device combination products. Further key findings from the study suggest: Transdermal patch ...
May 2024
150 pages
Alzheimer’s Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034
US$ 6,499.00
The Alzheimer’s disease market reached a value of US$ 3.1 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 6.3 Bil...
May 2024
140 pages
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major Chimeric Antigen Receptor (CAR) T-Cell Therapy markets reached a value of US$ 3,589.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11,282.5 Million by 2034, e...
May 2024
130 pages
Diffuse Large B-cell Lymphoma (DLBCL) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major Diffuse Large B-cell Lymphoma (DLBCL) markets reached a value of US$ 3,907.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,257.7 Million by 2034, exhibiting...
May 2024
132 pages
Idiopathic Pulmonary Fibrosis (IPF) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034
US$ 6,499.00
The 7 major Idiopathic Pulmonary Fibrosis (IPF) markets reached a value of US$ 3,586.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6,906.1 Million by 2034, exhibiting a...
May 2024
135 pages
Wet Age-Related Macular Degeneration (Wet AMD) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major Wet Age-Related Macular Degeneration (Wet AMD) markets reached a value of US$ 8,997.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 16,864.9 Million by 2034, e...
May 2024
129 pages
Breast Cancer Core Needle Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Technology (MRI-Based Breast Biopsy, Ultrasound-Based Breast Biopsy, Mammography-Based (Stereotactic) Breast Biopsy, CT-Based Breast Biopsy, Other Image Based Breast Biopsy), By End Use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology companies, Academic & Research Institutes), and By Region, Competition, 2019-2029F
US$ 4,500.00
Global Breast Cancer Core Needle Biopsy Market was valued at USD 0.80 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.90% through 2029. A Br...
May 2024
182 pages
Cardiac Resynchronization Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product (CRT-Defibrillator, CRT-Pacemaker), By End Use (Hospital, Cardiac Center, Others), and By Region, Competition, 2019-2029F
US$ 4,500.00
Global Cardiac Resynchronization Therapy Market was valued at USD 3.45 billion in 2023 and is anticipated to witness a steady growth in the forecast period with a CAGR of 3.70% through 2029. Cardiac R...
May 2024
185 pages
Cell Viability Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product (Consumables, Instruments), By Application (Drug Discovery and Development, Stem Cell Research, Diagnostics), By End Use (Biopharmaceuticals and Pharmaceutical Companies, CROs & CMOs, Academic and Research Institutes, Diagnostic Lab), and By Region, Competition, 2019-2029F
US$ 4,500.00
Global Cell Viability Assays Market was valued at USD 0.98 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.80% through 2029. Cell viability...
May 2024
182 pages
Digital Diabetes Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Product (Smart Glucose Meter, Continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, Apps), By Type (Wearable Devices, Handheld Devices), By End Use (Hospitals, Home Settings, Diagnostic Centers), and By Region, Competition, 2019-2029F
US$ 4,500.00
Global Digital Diabetes Management Market was valued at USD 14.60 billion in 2023 and is anticipated to grow in the forecast period with a CAGR of 9.30% through 2029. Digital diabetes management refe...
May 2024
183 pages
HLA Typing for Transplant Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Service (Reagents & Consumables, Instruments, Software & Services), By Technology (Molecular Assay Technologies, Non-molecular Assay Technologies), By Application (Diagnostic Applications, Antibody Screening, Chimerism Monitoring, Research Applications, Others), By Transplant Type (Solid Organ Transplant, Soft Tissue Transplant) Region and Competition, 2019-2029F
US$ 4,500.00
Global HLA Typing for Transplant Market was valued at USD 1.02 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 6.01% through 2029. The Global HLA Typ...
May 2024
185 pages
India Emerging Infectious Disease Diagnostics Market By Infection Type (Bacterial, Viral, Fungal, Others), By Technology (Polymerase Chain Reaction (PCR), Immunodiagnostics, Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), Others), By Region, Competition, Forecast and Opportunities, 2020-2030F
US$ 3,500.00
India Emerging Infectious Disease Diagnostics Market was valued at USD 317.63 million by 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 9.87% through 2030. Ind...
May 2024
83 pages
North America Corneal Implants Market By Implant Type (Artificial Corneal Implant, Human Corneal Implant), By Disease Indication (Keratoconus, Fuschs' Dystrophy, Infectious Keratitis, Corneal Ulcers, Other Disease Indications), By End User (Hospital & Clinics, Ambulatory Surgical Centers, Others), By Country, Competition, Forecast, and Opportunities, 2019-2029F
US$ 4,000.00
North America Corneal Implants Market was valued at USD 145.61 million in 2023 and is anticipated to grow with a CAGR of 5.81% through 2029. The North America Corneal Implants Market is a dynamic and...
May 2024
120 pages
Tinea Pedis Treatment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration (Oral, and Topical), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies, E-Pharmacies), By Region and Competition, 2019-2029F
US$ 4,500.00
Global Tinea Pedis Treatment Market was valued at USD 1.54 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.21% through 2029. The Global Tinea P...
May 2024
181 pages
Transfection Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Transfection Method (Cotransfection, Electroporation, Cationic Lipid Transfection, Lipofection, Nucleofection, In Vivo Transfection), By Product (Reagent, Instrument, Others), By Applications (Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming and Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Bio-Medical Research, Others), By Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection), By Region, and By Competition, 2019-2029F
US$ 4,900.00
Global Transfection Technologies Market was valued at USD 1.23 billion in 2023 and expected to experience impressive growth in the forecast period at a CAGR of 9.61% through 2029. Transfection techno...
May 2024
182 pages
Veterinary Rapid Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Test Kits, Readers), Testing (Virology, Parasitology, Bacteriology, Clinical Chemistry, Other), Technology (Immunoassays, PCR), Animal Type (Companion Animal (Dogs, Cats, Horses, Other), Production Animal (Cattle, Poultry, Swine, Other), End Use (Veterinary Hospitals & Clinics, Homecare Settings, Other) Region and Competition, 2019-2029F
US$ 4,500.00
Global Veterinary Rapid Test Market was valued at USD 822.11 million in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 9.01% through 2029. The Global Veterinar...
May 2024
183 pages
Abdominal Aortic Aneurysm Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major abdominal aortic aneurysm markets reached a value of US$ 1,692.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,235.2 Million by 2034, exhibiting a growth rat...
May 2024
135 pages
Abscess Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major abscess markets reached a value of US$ 869.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,253.3 Million by 2034, exhibiting a growth rate (CAGR) of 3.38% du...
May 2024
135 pages
Acute Kidney Injury Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major acute kidney injury markets reached a value of US$ 5,766.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9,904.0 Million by 2034, exhibiting a growth rate (CAG...
May 2024
140 pages
Acute Lymphoblastic Leukemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major acute lymphoblastic leukemia Markets reached a value of US$ 2,145.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4,003.7 Million by 2034, exhibiting a growth...
May 2024
133 pages
Acute Pancreatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major acute pancreatitis markets reached a value of US$ 695.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,062.9 Million by 2034, exhibiting a growth rate (CAGR)...
May 2024
130 pages
